Podiatry practices provide specialized medical and surgical care for foot, ankle, and lower extremity conditions, serving a patient base heavily weighted toward diabetics, elderly patients, and those with musculoskeletal disorders. The industry benefits from strong structural demand driven by the aging U.S. population, rising diabetes prevalence, and a national shortage of licensed podiatrists creating favorable supply-demand dynamics. Practices generate revenue through a mix of office visits, surgical procedures, orthotics, and ongoing chronic care management, often with stable Medicare reimbursement as a foundation.
Who buys these: Private equity-backed DSOs (Dental/Specialty Office platforms), healthcare-focused search fund operators, physician entrepreneurs, and individual podiatrists seeking to expand their practice footprint or transition from associate to owner
3–5.5×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Established podiatry practice with $1M–$5M in annual collections, positive EBITDA margins of 15–30%, minimum 3 years of operating history, diversified payer mix with Medicare under 60%, at least one associate podiatrist or mid-level provider, and a loyal patient base with recurring appointment volume
Get Deal Flow In Your Inbox
New Podiatry Practice acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Podiatry Practice acquisition
Seller Intelligence
Who sells Podiatry Practice businesses?
Retiring podiatrists aged 55–70 looking to exit after building a practice over 15–30 years, physician-owners experiencing burnout or seeking liquidity, and sole practitioners without a natural internal successor
Typical exit timeline: 12–24 months
Podiatry Practice businesses in the $1M–$5M revenue range typically sell for 3–5.5× EBITDA. Established podiatry practice with $1M–$5M in annual collections, positive EBITDA margins of 15–30%, minimum 3 years of operating history, diversified payer mix with Medicare under 60%, at least one associate podiatrist or mid-level provider, and a loyal patient base with recurring appointment volume
Podiatry Practice businesses typically trade at 3–5.5× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Podiatry Practice businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Asset purchase with seller earnout tied to patient retention and revenue targets over 12–24 months post-close
Key due diligence areas include: Payer mix analysis and reimbursement rate trends including Medicare/Medicaid concentration risk; Physician employment agreements, non-compete clauses, and transition/earnout structure for the selling physician; Accounts receivable aging, billing accuracy, and coding compliance to identify revenue cycle vulnerabilities; State licensure requirements, corporate practice of medicine laws, and any prior malpractice or compliance actions; Patient retention history, appointment volume trends, and referral source concentration.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers